Macular telangiectasia type 2
暂无分享,去创建一个
Emily Y. Chew | Frank G. Holz | Tunde Peto | Mark C. Gillies | Hendrik P.N. Scholl | E. Chew | T. Peto | A. Bird | M. Gillies | F. Holz | H. Scholl | P. C. Issa | Peter Charbel Issa | Alan C. Bird | Tjebo F.C. Heeren | T. Heeren
[1] S. Charles,et al. Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.
[2] K. Nishida,et al. Comparison of macular pigment in three types of macular telangiectasia , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.
[3] Ling Zhu,et al. Conditional Müller Cell Ablation Causes Independent Neuronal and Vascular Pathologies in a Novel Transgenic Model , 2012, The Journal of Neuroscience.
[4] R. Pappuru,et al. EFFICACY OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN SUBRETINAL NEOVASCULARIZATION SECONDARY TO MACULAR TELANGIECTASIA TYPE 2 , 2012, Retina.
[5] R. Venkatesh,et al. Spontaneous closure of full-thickness macular hole in type 2 idiopathic macular telangiectasia , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.
[6] A. Tsujikawa,et al. RETINAL STRUCTURAL ALTERATIONS AND MACULAR SENSITIVITY IN IDIOPATHIC MACULAR TELANGIECTASIA TYPE 1 , 2012, Retina.
[7] Catherine Egan,et al. "En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. , 2012, Investigative ophthalmology & visual science.
[8] G. Hageman,et al. Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia , 2012, British Journal of Ophthalmology.
[9] A. Bird,et al. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis. , 2012, Investigative ophthalmology & visual science.
[10] Krzysztof Kiryluk,et al. Identification of a Potential Susceptibility Locus for Macular Telangiectasia Type 2 , 2012, PloS one.
[11] Irene Leung,et al. The Prevalence of Type 2 Idiopathic Macular Telangiectasia in Two African Populations , 2012, Ophthalmic epidemiology.
[12] Brian C. Toy,et al. TREATMENT OF NONNEOVASCULAR IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 WITH INTRAVITREAL RANIBIZUMAB: Results of a Phase II Clinical Trial , 2012, Retina.
[13] G. Hageman,et al. Pilot application of iTRAQ to the retinal disease Macular Telangiectasia. , 2012, Journal of proteome research.
[14] H. Oyamada,et al. Demographic features of idiopathic macular telangiectasia in Japanese patients , 2012, Japanese Journal of Ophthalmology.
[15] J. Jonas,et al. Intravitreal bevacizumab for perifoveal telangiectasia , 2011, Acta ophthalmologica.
[16] Michael D Abramoff,et al. INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF PROLIFERATIVE AND NONPROLIFERATIVE TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA , 2011, Retina.
[17] A. Tsujikawa,et al. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy. , 2011, Investigative ophthalmology & visual science.
[18] S. Kang,et al. Clinical Features of Idiopathic Juxtafoveal Telangiectasis in Koreans , 2011, Korean journal of ophthalmology : KJO.
[19] F. Holz,et al. Erratum: Monthly ranibizumab for nonproliferative macular telangiectasia type 2: A 12-month prospective study (American Journal of Ophthalmology (2011) 151:5 (876-886)) , 2011 .
[20] Peter M. G. Munro,et al. Basement membrane changes in capillaries of the ageing human retina , 2011, British Journal of Ophthalmology.
[21] P. Charbel Issa,et al. Monthly ranibizumab for nonproliferative macular telangiectasia type 2: a 12-month prospective study. , 2011, American journal of ophthalmology.
[22] R. Guymer,et al. The longitudinal impact of macular telangiectasia (MacTel) type 2 on vision-related quality of life. , 2011, Investigative ophthalmology & visual science.
[23] P. Bernstein,et al. Identification of StARD3 as a lutein-binding protein in the macula of the primate retina. , 2011, Biochemistry.
[24] D. Shukla. Evolution and management of macular hole secondary to type 2 idiopathic macular telangiectasia , 2011, Eye.
[25] M. Gillies,et al. Submacular DL-alpha-aminoadipic acid eradicates primate photoreceptors but does not affect luteal pigment or the retinal vasculature. , 2011, Investigative ophthalmology & visual science.
[26] Tunde Peto,et al. Analysis of candidate genes for macular telangiectasia type 2 , 2010, Molecular vision.
[27] R. Guymer,et al. Perifoveal müller cell depletion in a case of macular telangiectasia type 2. , 2010, Ophthalmology.
[28] Steffen Schmitz-Valckenberg,et al. Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2. , 2010, Ophthalmology.
[29] U. Schmidt-Erfurth,et al. Thirty-month follow-up after intravitreal bevacizumab in progressive idiopathic macular telangiectasia type 2 , 2010, Eye.
[30] D. Pauleikhoff,et al. MACULAR TELANGIECTASIA: Patterns of Distribution of Macular Pigment and Response to Supplementation , 2010, Retina.
[31] M. Yuzawa,et al. Intravitreal bevacizumab therapy for idiopathic macular telangiectasia , 2010, Japanese Journal of Ophthalmology.
[32] R. Lira,et al. Intravitreous ranibizumab as treatment for macular telangiectasia type 2. , 2010, Archives of ophthalmology.
[33] A. Wenzel,et al. Bone spicule pigment formation in retinitis pigmentosa: insights from a mouse model , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[34] H. Flynn,et al. Surgery for full-thickness macular hole in patients with idiopathic macular telangiectasia type 2. , 2010, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[35] Ronald Klein,et al. The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study. , 2010, American journal of ophthalmology.
[36] P. Charbel Issa,et al. Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2 , 2010, International Ophthalmology.
[37] J. Cruysberg,et al. Patients with Sjögren-Larsson syndrome lack macular pigment. , 2010, Ophthalmology.
[38] A. Tsujikawa,et al. Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia , 2010, Eye.
[39] David Williams,et al. Retinal crystals in type 2 idiopathic macular telangiectasia. , 2010, Ophthalmology (Rochester, Minn.).
[40] Robert Finger,et al. Structure-Function Correlation of the Human Central Retina , 2010, PloS one.
[41] D. Pauleikhoff,et al. IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2: DISTRIBUTION OF MACULAR PIGMENT AND FUNCTIONAL INVESTIGATIONS , 2010, Retina.
[42] C. Kramann,et al. [Idiopathic macular telangiectasia - follow-up with and without laser photocoagulation]. , 2010, Klinische Monatsblatter fur Augenheilkunde.
[43] R. Guymer,et al. THE PREVALENCE ESTIMATES OF MACULAR TELANGIECTASIA TYPE 2: The Melbourne Collaborative Cohort Study , 2010, Retina.
[44] E. Souied,et al. Type II Idiopathic Macular Telangiectasia and Soft Confluent Drusen , 2010, European journal of ophthalmology.
[45] G. Staurenghi,et al. INTEGRATED CLINICAL EVALUATION OF TYPE 2A IDIOPATHIC JUXTAFOVEOLAR RETINAL TELANGIECTASIS , 2010, Retina.
[46] Tunde Peto,et al. Baseline Characteristics of Participants in the Natural History Study of Macular Telangiectasia (MacTel) MacTel Project Report No. 2 , 2010, Ophthalmic epidemiology.
[47] Hendrik P N Scholl,et al. Familial asymptomatic macular telangiectasia type 2. , 2009, Ophthalmology.
[48] C. Pournaras,et al. Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A , 2009, Acta ophthalmologica.
[49] V. Mahajan,et al. A new macular dystrophy with anomalous vascular development, pigment spots, cystic spaces, and neovascularization. , 2009, Archives of ophthalmology.
[50] N. Osborne,et al. Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects , 2009, Progress in Retinal and Eye Research.
[51] Denise Cunningham,et al. Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry. , 2009, American journal of ophthalmology.
[52] G. Rubin,et al. STRUCTURAL AND FUNCTIONAL CHANGES OVER TIME IN MacTel PATIENTS , 2009, Retina.
[53] Frank G. Holz,et al. Metamorphopsia in patients with macular telangiectasia type 2 , 2009, Documenta Ophthalmologica.
[54] A. Erginay,et al. Spectral domain optical coherence tomography in type 2 idiopathic perifoveal telangiectasia. , 2009, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[55] I. Mantel,et al. Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.
[56] T. Berendschot,et al. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. , 2009, Experimental eye research.
[57] Binxing Li,et al. Purification and partial characterization of a lutein-binding protein from human retina. , 2009, Biochemistry.
[58] P. Charbel Issa,et al. The article by Kovach and Rosenfeld. , 2009, Retina.
[59] Oscar Yanes,et al. Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress. , 2009, The Journal of clinical investigation.
[60] Hendrik P N Scholl,et al. Reading performance is reduced by parafoveal scotomas in patients with macular telangiectasia type 2. , 2009, Investigative ophthalmology & visual science.
[61] U. Kellner,et al. Klinik und Diagnostik der Zapfen-Dystrophien , 2009, Der Ophthalmologe.
[62] J. Shaw,et al. Retinal vascular caliber and macular telangiectasia type 2. , 2009, Ophthalmology.
[63] D. Steel,et al. Comment on macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia. , 2009 .
[64] Philip J Rosenfeld,et al. BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II , 2009, Retina.
[65] I. Georgalas,et al. A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis , 2008, Clinical interventions in aging.
[66] P. Rosenfeld,et al. Macular spectral-domain optical coherence tomography in patients with X linked retinoschisis , 2008, British Journal of Ophthalmology.
[67] Magali Saint-Geniez,et al. Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors , 2008, PloS one.
[68] Tunde Peto,et al. The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project. , 2008, Investigative ophthalmology & visual science.
[69] I. Maruko,et al. Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry , 2008, British Journal of Ophthalmology.
[70] V. Kozousek,et al. Intravitreal bevacizumab compared with photodynamic therapy with verteporfin for group 2a parafoveal retinal telangiectasis. , 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[71] M. Burnier,et al. Intravitreal pegaptanib reduces fluorescein leakage in idiopathic parafoveal telangiectasis. , 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[72] Daniel Barthelmes,et al. Differential optical densities of intraretinal spaces. , 2008, Investigative ophthalmology & visual science.
[73] F. Holz,et al. Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia , 2008, British Journal of Ophthalmology.
[74] R. Zawadzki,et al. Retinal morphological changes of patients with X-linked retinoschisis evaluated by Fourier-domain optical coherence tomography. , 2008, Archives of ophthalmology.
[75] P. Charbel Issa,et al. A new diagnostic approach in patients with type 2 macular telangiectasia: confocal reflectance imaging , 2008, Acta ophthalmologica.
[76] H. Scholl,et al. ABNORMAL MACULAR PIGMENT DISTRIBUTION IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA , 2008, Retina.
[77] M. Gillies,et al. Quantitative OCT analysis of idiopathic perifoveal telangiectasia. , 2008, Investigative ophthalmology & visual science.
[78] J. Cruysberg,et al. Subclinical changes in the juvenile crystalline macular dystrophy in Sjögren-Larsson syndrome detected by optical coherence tomography. , 2008, Ophthalmology.
[79] H. Sachs,et al. Bevacizumab in the treatment of idiopathic macular telangiectasia , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.
[80] T. Berendschot,et al. Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. , 2008, Investigative ophthalmology & visual science.
[81] G. Rubin,et al. Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia. , 2008, Archives of ophthalmology.
[82] J. F. Arevalo,et al. LONG-TERM EFFECT OF INTRAVITREAL TRIAMCINOLONE IN THE NONPROLIFERATIVE STAGE OF TYPE II IDIOPATHIC PARAFOVEAL TELANGIECTASIA , 2008, Retina.
[83] P. Rishi,et al. Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.
[84] Z. Ablonczy,et al. VEGF modulation of retinal pigment epithelium resistance. , 2007, Experimental eye research.
[85] A. Lotery,et al. Idiopathic juxtafoveolar retinal telangiectasis in monozygotic twins , 2007, British Journal of Ophthalmology.
[86] E. Stone,et al. ABCA4 mutations and discordant ABCA4 alleles in patients and siblings with bull’s-eye maculopathy , 2007, British Journal of Ophthalmology.
[87] R. Spaide,et al. Centripetal retinal capillary proliferation in idiopathic parafoveolar telangiectasis , 2007, British Journal of Ophthalmology.
[88] M. Shanmugam,et al. Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane , 2007, Indian journal of ophthalmology.
[89] J. J. Laey,et al. Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane , 2007, Eye.
[90] P. Charbel Issa,et al. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. , 2007, Ophthalmology.
[91] P. Charbel Issa,et al. Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia. , 2007, Investigative ophthalmology & visual science.
[92] B. Takahashi,et al. Intravitreal bevacizumab for foveal detachment in idiopathic perifoveal telangiectasia. , 2007, American journal of ophthalmology.
[93] David T. Shima,et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. , 2007, The American journal of pathology.
[94] I. Scott,et al. Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[95] P. Sieving,et al. Preventing blindness in retinal disease: ciliary neurotrophic factor intraocular implants. , 2007, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[96] V. Gabel,et al. Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[97] Stefan Schinkinger,et al. Müller cells are living optical fibers in the vertebrate retina , 2007, Proceedings of the National Academy of Sciences.
[98] J. Slakter,et al. FULL-THICKNESS MACULAR HOLE FORMATION IN IDIOPATHIC PARAFOVEAL TELANGIECTASIS , 2007, Retina.
[99] M. Parodi,et al. Subretinal neovascular membrane associated with type 2a idiopathic juxtafoveolar telangiectasis in pseudoxanthoma elasticum , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[100] P. Venkatesh,et al. Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[101] L. Drolsum,et al. Iris microhaemangiomas and idiopathic juxtafoveolar retinal telangiectasis. , 2006, Acta ophthalmologica Scandinavica.
[102] O. M. O. Júnior,et al. Injeção intravítrea de triancinolona no tratamento da telangiectasia retiniana justafoveolar idiopática , 2006 .
[103] Alain Gaudric,et al. Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. , 2006, Archives of ophthalmology.
[104] E. Rakoczy,et al. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. , 2006, Investigative ophthalmology & visual science.
[105] Michael D. Ober,et al. ANECORTAVE ACETATE FOR THE TREATMENT OF IDIOPATHIC PERIFOVEAL TELANGIECTASIA: A Pilot Study , 2006, Retina.
[106] Z. Kapran,et al. Optical Coherence Tomography Evaluation of Macular Edema after Intravitreal Triamcinolone Acetonide in Patients with Parafoveal Telangiectasis , 2006, European journal of ophthalmology.
[107] H. Koizumi,et al. Morphologic features of group 2A idiopathic juxtafoveolar retinal telangiectasis in three-dimensional optical coherence tomography. , 2006, American journal of ophthalmology.
[108] Peter Wiedemann,et al. Müller cells in the healthy and diseased retina , 2006, Progress in Retinal and Eye Research.
[109] Mauget-Faÿsse Martine,et al. Optical coherence tomography in tamoxifen retinopathy , 2006, Breast Cancer Research and Treatment.
[110] R. Danis,et al. Macular pigment: a review of current knowledge. , 2006, Archives of ophthalmology.
[111] J. F. Arevalo,et al. Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.
[112] Maciej Wojtkowski,et al. Retinal assessment using optical coherence tomography , 2006, Progress in Retinal and Eye Research.
[113] L. Yannuzzi,et al. Idiopathic Macular Telangiectasia , 2006, Retina.
[114] Weng Tao,et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[115] R. Lakhanpal,et al. Optical coherence tomography of idiopathic juxtafoveolar telangiectasia. , 2006, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[116] J. Olson,et al. Macular hole formation associated with idiopathic parafoveal telangiectasia , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.
[117] W. Chan,et al. Use of intravitreal triamcinolone acetonide injection in unilateral idiopathic juxtafoveal telangiectasis , 2005, Clinical & experimental ophthalmology.
[118] J. Sahel,et al. Optical coherence tomography findings in tamoxifen retinopathy. , 2005, American journal of ophthalmology.
[119] J. Folk,et al. LONG-TERM JUXTAFOVEAL RETINAL TELANGIECTASIA , 2005, Retina.
[120] T. Das,et al. Bilateral sequential photodynamic therapy for sub-retinal neovascularization with type 2A parafoveal telangiectasis. , 2005, American journal of ophthalmology.
[121] W. Shen,et al. Generation of transgenic mice with mild and severe retinal neovascularisation , 2005, British Journal of Ophthalmology.
[122] S. Fekrat,et al. Group 2A idiopathic juxtafoveolar retinal telangiectasia in monozygotic twins. , 2005, American journal of ophthalmology.
[123] Paul S Bernstein,et al. Identification and Characterization of a Pi Isoform of Glutathione S-Transferase (GSTP1) as a Zeaxanthin-binding Protein in the Macula of the Human Eye* , 2004, Journal of Biological Chemistry.
[124] Salomon Y. Cohen,et al. Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization. , 2004, American journal of ophthalmology.
[125] R. Spaide,et al. Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis. , 2004, American journal of ophthalmology.
[126] A. Morland,et al. Macular pigments: their characteristics and putative role , 2004, Progress in Retinal and Eye Research.
[127] R. Kim,et al. Transpupillary thermotherapy for subfoveal neovascularization secondary to group 2A idiopathic juxtafoveolar telangiectasis. , 2004, American journal of ophthalmology.
[128] F. Davidorf,et al. Juxtafoveal telangiectasis-a name change? , 2004, Retina.
[129] L. Postelmans,et al. Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. , 2004, American journal of ophthalmology.
[130] A. Ho,et al. Idiopathic juxtafoveal telangiectasis in association with celiac sprue. , 2004, Archives of ophthalmology.
[131] Jose A. Martinez. Intravitreal triamcinolone acetonide for bilateral acquired parafoveal telangiectasis. , 2003, Archives of ophthalmology.
[132] Shigeki Hashimoto,et al. Quantification of metamorphopsia in patients with epiretinal membranes. , 2003, Investigative ophthalmology & visual science.
[133] Martin Friedlander,et al. MOUSE MODEL OF SUBRETINAL NEOVASCULARIZATION WITH CHOROIDAL ANASTOMOSIS , 2003, Retina.
[134] R. Hutchins,et al. Photodynamic therapy with verteporfin for subretinal neovascularization secondary to bilateral idiopathic acquired juxtafoveolar telangiectasis. , 2003, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[135] D. Sarraf,et al. West African crystalline maculopathy. , 2003, Archives of ophthalmology.
[136] B. Garretson,et al. Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. , 2003, Retina.
[137] S. Sadda,et al. Idiopathic parafoveal telangiectasis associated with a foveal pseudovitelliform lesion , 2002, The British journal of ophthalmology.
[138] Weng Tao,et al. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. , 2002, Investigative ophthalmology & visual science.
[139] W. Hauswirth,et al. Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation. , 2002, Experimental eye research.
[140] T. Hebert,et al. Adaptive optics scanning laser ophthalmoscopy. , 2002, Optics express.
[141] A. Bird,et al. Clinical variations in assessment of bull's-eye maculopathy. , 2002, Archives of ophthalmology.
[142] M. Seeliger,et al. Inactivation of the murine X-linked juvenile retinoschisis gene, Rs1h, suggests a role of retinoschisin in retinal cell layer organization and synaptic structure , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[143] T. Aaberg,et al. Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis. , 2002, Archives of ophthalmology.
[144] S. Trauzettel-Klosinski. Reading disorders due to visual field defects: a neuro-ophthalmological view , 2002 .
[145] M. O'Keefe,et al. Classification of the spectrum of Coats' disease as subtypes of idiopathic retinal telangiectasis with exudation. , 2001, Acta ophthalmologica Scandinavica.
[146] T. Aleman,et al. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[147] N. Bressler,et al. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.
[148] J. Cruysberg,et al. Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome. , 2000, American journal of ophthalmology.
[149] M. T. Bonanomi,et al. Idiopathic Juxtafoveolar Retinal Telangiectasis: Clinical Pattern in 19 Cases , 2000, Ophthalmologica.
[150] J. Bausch,et al. Dose dependency of canthaxanthin crystals in monkey retina and spatial distribution of its metabolites. , 2000, Investigative ophthalmology & visual science.
[151] G. Virgili,et al. Bilateral juxtafoveolar telangiectasis in monozygotic twins. , 2000, American journal of ophthalmology.
[152] L. Lagae,et al. FAMILIAL SPASTIC PARAPLEGIA AND MACULOPATHY WITH JUXTAFOVEOLAR RETINAL TELANGIECTASIS AND SUBRETINAL NEOVASCULARIZATION , 2000, Retina.
[153] E. Chew,et al. Radiation exposure: a new risk factor for idiopathic perifoveal telangiectasis. , 1999, Ophthalmology.
[154] A. Bird,et al. Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. , 1999, Investigative ophthalmology & visual science.
[155] D. Park,et al. Bilateral juxtafoveal telangiectasis in a family. , 1999, Retina.
[156] C. Gravel,et al. Intraocular Gene Transfer of Ciliary Neurotrophic Factor Prevents Death and Increases Responsiveness of Rod Photoreceptors in theretinal degeneration slow mouse , 1998, The Journal of Neuroscience.
[157] M. Lavail,et al. Protection of mouse photoreceptors by survival factors in retinal degenerations. , 1998, Investigative ophthalmology & visual science.
[158] M. Lowe,et al. Laser photocoagulation and glucose metabolism in idiopathic juxtafoveolar retinal telangiectasis. , 1998, Ophthalmic surgery and lasers.
[159] D. Park,et al. Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. , 1997, Ophthalmology.
[160] P. Campochiaro,et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.
[161] C. Gravel,et al. Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. , 1997, Human gene therapy.
[162] J. Bausch,et al. Occurrence of birefringent retinal inclusions in cynomolgus monkeys after high doses of canthaxanthin. , 1997, Investigative ophthalmology & visual science.
[163] D. Park,et al. Fibrovascular tissue in bilateral juxtafoveal telangiectasis. , 1996, Archives of ophthalmology.
[164] J. Nasemann,et al. [Idiopathic juxtafoveolar telangiectasis. Long-term follow-up of visual acuity]. , 1995, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[165] C K Dorey,et al. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. , 1995, Investigative ophthalmology & visual science.
[166] B. Blodi,et al. Idiopathic juxtafoveolar retinal telangiectasis , 1993 .
[167] S. Friedman,et al. Subretinal hemorrhage after grid laser photocoagulation for idiopathic juxtafoveolar retinal telangiectasis. , 1993, Ophthalmic surgery.
[168] R. Murphy,et al. Superficial retinal refractile deposits in juxtafoveal telangiectasis. , 1990, American journal of ophthalmology.
[169] J. Duvall,et al. Lamellar macular hole associated with idiopathic juxtafoveolar telangiectasia. , 1988, The British journal of ophthalmology.
[170] A. Bird,et al. Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. , 1987, Brain : a journal of neurology.
[171] M. Klein,et al. Abnormal glucose metabolism and parafoveal telangiectasia. , 1986, American journal of ophthalmology.
[172] A. Bird,et al. Retinal telangiectasis in facioscapulohumeral muscular dystrophy with deafness. , 1985, Archives of ophthalmology.
[173] D M Snodderly,et al. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. , 1984, Investigative ophthalmology & visual science.
[174] F. Delori,et al. The macular pigment. II. Spatial distribution in primate retinas. , 1984, Investigative ophthalmology & visual science.
[175] J. Gass,et al. Idiopathic juxtafoveolar retinal telangiectasis. , 1982, Archives of ophthalmology.
[176] W. Green,et al. Parafoveal retinal telangiectasis: Light and electron microscopy studies , 1980, Transactions of the ophthalmological societies of the United Kingdom.
[177] D. Fuller,et al. Focal parafoveal retinal telangiectasis. , 1978, Archives of ophthalmology.
[178] A. Chopdar. Retinal telangiectasis in adults: fluorescein angiographic findings and treatment by argon laser. , 1978, The British journal of ophthalmology.
[179] C. Clemente. HISTOLOGY OF THE HUMAN EYE : An Atlas and Textbook , 1973 .
[180] D. Worthen,et al. Histology of the Human Eye. , 1972 .
[181] H. Gerrits,et al. The filling-in process in patients with retinal scotomata. , 1969, Vision research.
[182] J. Gass. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. V. Retinal telangiectasis. , 1968, Archives of ophthalmology.
[183] J. Gass. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. VI. X-ray irradiation, carotid artery occlusion, collagen vascular disease, and vitritis. , 1968, Archives of ophthalmology.
[184] A. B. Reese,et al. Telangiectasis of the retina and Coats' disease. , 1956, American journal of ophthalmology.
[185] Lien Delaere,et al. Vertical transmission of macular telangiectasia type 2. , 2012, Retinal cases & brief reports.
[186] L. Yannuzzi,et al. Peculiar manifestation of macular telangiectasia type 2. , 2011, Retinal cases & brief reports.
[187] L. Yannuzzi. The retinal atlas , 2010 .
[188] P. Massin,et al. Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia , 2009, Eye.
[189] P. Charbel Issa,et al. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia. , 2008, American journal of ophthalmology.
[190] B. J. Klevering,et al. Analysis of visual pigment by fundus autofluorescence. , 2008, Experimental eye research.
[191] A. Bird,et al. Macular pigment in the human retina: histological evaluation of localization and distribution , 2008, Eye.
[192] V. Arshavsky,et al. Progress in Retinal and Eye Research , 2008 .
[193] P. Charbel Issa,et al. Short-term effects of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. , 2007, Retinal cases & brief reports.
[194] F. Recchia,et al. Neurosensory macular detachment in group 2a juxtafoveolar telangiectasis and resolution following intravitreal triamcinolone. , 2007, Retinal cases & brief reports.
[195] M. Gillies,et al. A case of idiopathic perifoveal telangiectasia preceded by features of cone dystrophy , 2007, Eye.
[196] M. Potter,et al. Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis. , 2006, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[197] Atul K. Jain,et al. Crystalline retinopathies. , 2006, Survey of ophthalmology.
[198] M. Shanmugam,et al. RPE atrophy following photodynamic therapy in type 2A idiopathic parafoveal telangiectasis. , 2005, Indian journal of ophthalmology.
[199] J. Gass. Juxtafoveal telangiectasis-a name change? , 2005, Retina.
[200] M. Potter,et al. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. , 2002, American journal of ophthalmology.
[201] S. Harding. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials¿TAP Report No. 5 , 2002 .
[202] W. Green,et al. Histopathologic study of presumed parafoveal telangiectasis. , 1999, Retina.
[203] N. Bressler. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. , 2001 .
[204] P. Campochiaro,et al. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. , 1998, Investigative ophthalmology & visual science.
[205] G. Brown,et al. Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. , 1997, Retina.
[206] I. McAllister,et al. Familial idiopathic juxtafoveolar retinal telangiectasis , 1996, Eye.
[207] B. L. Lee. Bilateral subretinal neovascular membrane in idiopathic juxtafoveolar telangiectasis. , 1996, Retina.
[208] J. Nasemann,et al. Idiopathische juxtafoveoläre Teleangiektasien. Langzeitverlauf des Sehvermögens. , 1995 .
[209] A. Mansour,et al. Foveal avascular zone in idiopathic juxtafoveolar telangiectasia. , 1993, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[210] A. Bird,et al. Paramacular telangiectasis. , 1986, Transactions of the ophthalmological societies of the United Kingdom.
[211] E. Chew,et al. Parafoveal telangiectasis and diabetic retinopathy. , 1986, Archives of ophthalmology.
[212] Y. Taniguchi,et al. Retinal vascular patterns in the macula and the perimacular area in premature and full-term infants. , 1982, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[213] Hogan,et al. Histology of the human eye;: An atlas and textbook , 1971 .